Advertisement
Canada markets open in 4 hours 42 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7314
    +0.0017 (+0.23%)
     

  • CRUDE OIL

    83.19
    +0.38 (+0.46%)
     

  • Bitcoin CAD

    87,284.67
    -3,744.06 (-4.11%)
     

  • CMC Crypto 200

    1,362.07
    -20.50 (-1.48%)
     

  • GOLD FUTURES

    2,339.80
    +1.40 (+0.06%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,500.00
    -164.50 (-0.93%)
     

  • VOLATILITY

    16.20
    +0.23 (+1.44%)
     

  • FTSE

    8,091.89
    +51.51 (+0.64%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6816
    -0.0003 (-0.04%)
     

Today’s Research Reports on Trending Tickers: Astrazeneca and Endo International

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / November 24, 2017 / Heading into Thanksgiving weekend the Dow Jones and S&P 500 pulled back from record highs after minutes from the Federal Reserve meeting were released, while the Nasdaq closed at another record high as tech giant Amazon Inc. surged 1.46 percent. The Dow Jones Industrial Average declined 0.27 percent to close at 23,526.18, while the S&P 500 Index decreased 0.08 percent to close at 2,597.08. The Nasdaq Composite Index eked out a 0.07 percent gain to close at 6,867.36.

"The November FOMC Minutes showed a committee that sees economic momentum building in the near term but remains uncertain about the inflation outlook. Overall, we read the November minutes as dovish. The upgrade to the economic assessment notwithstanding, the minutes show there is still considerable unease about hiking when inflation keeps surprising to the downside. We continue to expect that a December hike is baked in," said a team of BNP Paribas economists led by Paul Mortimer-Lee, according to MarketWatch.

RDI Initiates Coverage on:

Astrazeneca PLC
https://rdinvesting.com/news/?ticker=AZN

ADVERTISEMENT

Endo International plc
https://rdinvesting.com/news/?ticker=ENDP

Astrazeneca PLC's stock edged 0.30% higher Wednesday, to close the day at $33.83. The stock recorded a trading volume of 1,277,344 shares, which was below its three months average volume of 4,004,412 shares. In the last year, Astrazeneca PLC's shares have traded in a range of 25.55 - 35.60. The share price has gained 32.41% from its 52-week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $34.03 is greater than its 200-day moving average of $32.94. Shares of Astrazeneca PLC are trading at a Price to Earnings ratio of 22.19. Shares of Astrazeneca PLC have fallen roughly 1.63 percent in the past month and are up 23.83 percent year-to-date.

Access RDI's Astrazeneca PLC Research Report at:
https://rdinvesting.com/news/?ticker=AZN

On Wednesday, shares in Endo International plc recorded a trading volume of 3,044,073 shares, which was below the three months average volume of 6,151,000 shares. The stock ended the day 0.79% higher at 7.63. The share price has gained 32.24% from its 52-week low with a 52-week trading range of 5.77 - 17.99.The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $7.28 is below its 200-day moving average of $9.73. Shares of Endo International plc have gained roughly 2.01 percent in the past month and are down 53.67 percent year-to-date.

Access RDI's Endo International plc Research Report at:
https://rdinvesting.com/news/?ticker=ENDP

Our Actionable Research on Astrazeneca PLC (NYSE:AZN) and Endo International plc (NASDAQ:ENDP) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com